Progress of coronary artery disease: compliance to therapy

A Pistevos1, J Georgiou, I Darsinos

  • 1Alexandra Hospital, Athens, Greece.

Angiology
|July 1, 1989
PubMed

Insights

Coronary artery disease (CAD) progresses rapidly in men, often from angina to myocardial infarction, especially with poor therapy compliance. Women experience a delayed onset and progression of CAD, with similar rates of angina and myocardial infarction in later stages.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Coronary artery disease (CAD) is a leading cause of mortality worldwide.
  • Understanding disease progression and recurrence patterns is crucial for patient management.
  • Factors influencing CAD recurrence, such as sex and treatment compliance, require further investigation.

Purpose of the Study:

  • To analyze the patterns of first and second manifestations of coronary artery disease (CAD) in male and female patients.
  • To investigate the influence of patient compliance to therapy on CAD recurrence.
  • To compare the age and type of initial and subsequent CAD events.

Main Methods:

  • Retrospective analysis of 1,824 patients with diagnosed coronary artery disease (CAD).
  • Categorization of patients by sex (male/female) and type of CAD manifestation (angina/myocardial infarction).
  • Assessment of patient compliance to prescribed therapy and its correlation with disease progression.

Main Results:

  • In males, the first CAD manifestation was angina (A) in 61% and myocardial infarction (MI) in 39% (at a younger age).
  • For males with initial angina, the second manifestation was MI in 61% of cases, more frequent with poor compliance.
  • Females presented with initial angina in 88% of cases, with a delayed second manifestation of MI and A in nearly equal proportions.

Conclusions:

  • Males with CAD show a rapid progression, with a higher likelihood of MI as a second event, particularly with poor therapy adherence.
  • Females experience a delayed onset of CAD, with subsequent events presenting as angina or MI at similar rates.
  • Therapeutic compliance plays a significant role in modulating the risk of myocardial infarction following an initial angina event in males.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
279
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
253
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
305
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
800
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
188
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
540